Cooper WN - Search Results

1

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias.

Hesson LB, Dunwell TL, Cooper WN, Catchpoole D, Brini AT, Chiaramonte R, Griffiths M, Chalmers AD, Maher ER, Latif F. Hesson LB, et al. Among authors: cooper wn. Mol Cancer. 2009 Jul 1;8:42. doi: 10.1186/1476-4598-8-42. Mol Cancer. 2009. PMID: 19570220 Free PMC article.

2

Evaluation of the 3p21.3 tumour-suppressor gene cluster.

Hesson LB, Cooper WN, Latif F. Hesson LB, et al. Among authors: cooper wn. Oncogene. 2007 Nov 15;26(52):7283-301. doi: 10.1038/sj.onc.1210547. Epub 2007 May 28. Oncogene. 2007. PMID: 17533367 Review.

3

Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.

Cooper WN, Dickinson RE, Dallol A, Grigorieva EV, Pavlova TV, Hesson LB, Bieche I, Broggini M, Maher ER, Zabarovsky ER, Clark GJ, Latif F. Cooper WN, et al. Oncogene. 2008 Mar 13;27(12):1805-11. doi: 10.1038/sj.onc.1210805. Epub 2007 Sep 24. Oncogene. 2008. PMID: 17891178 Free PMC article.

4

Role of the Ras-association domain family 1 tumor suppressor gene in human cancers.

Agathanggelou A, Cooper WN, Latif F. Agathanggelou A, et al. Among authors: cooper wn. Cancer Res. 2005 May 1;65(9):3497-508. doi: 10.1158/0008-5472.CAN-04-4088. Cancer Res. 2005. PMID: 15867337 Review.

5

The role of RASSF1A methylation in cancer.

Hesson LB, Cooper WN, Latif F. Hesson LB, et al. Among authors: cooper wn. Dis Markers. 2007;23(1-2):73-87. doi: 10.1155/2007/291538. Dis Markers. 2007. PMID: 17325427 Free PMC article. Review.

6

The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathways.

Lock FE, Underhill-Day N, Dunwell T, Matallanas D, Cooper W, Hesson L, Recino A, Ward A, Pavlova T, Zabarovsky E, Grant MM, Maher ER, Chalmers AD, Kolch W, Latif F. Lock FE, et al. Oncogene. 2010 Jul 29;29(30):4307-16. doi: 10.1038/onc.2010.192. Epub 2010 May 31. Oncogene. 2010. PMID: 20514026

7

Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas.

Margetts CD, Astuti D, Gentle DC, Cooper WN, Cascon A, Catchpoole D, Robledo M, Neumann HP, Latif F, Maher ER. Margetts CD, et al. Among authors: cooper wn. Endocr Relat Cancer. 2005 Mar;12(1):161-72. doi: 10.1677/erc.1.00865. Endocr Relat Cancer. 2005. PMID: 15788647

8

Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.

Astuti D, Latif F, Wagner K, Gentle D, Cooper WN, Catchpoole D, Grundy R, Ferguson-Smith AC, Maher ER. Astuti D, et al. Among authors: cooper wn. Br J Cancer. 2005 Apr 25;92(8):1574-80. doi: 10.1038/sj.bjc.6602478. Br J Cancer. 2005. PMID: 15798773 Free PMC article.

9

RASSF2 associates with and stabilizes the proapoptotic kinase MST2.

Cooper WN, Hesson LB, Matallanas D, Dallol A, von Kriegsheim A, Ward R, Kolch W, Latif F. Cooper WN, et al. Oncogene. 2009 Aug 20;28(33):2988-98. doi: 10.1038/onc.2009.152. Epub 2009 Jun 15. Oncogene. 2009. PMID: 19525978 Free PMC article.

10

Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer.

Wagner KJ, Cooper WN, Grundy RG, Caldwell G, Jones C, Wadey RB, Morton D, Schofield PN, Reik W, Latif F, Maher ER. Wagner KJ, et al. Among authors: cooper wn. Oncogene. 2002 Oct 17;21(47):7277-82. doi: 10.1038/sj.onc.1205922. Oncogene. 2002. PMID: 12370819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters